Evidence map›Paper›PMID 22697426›Full record

ArticleTissue engineering. Part A2012

Fast-degradable microbeads encapsulating human umbilical cord stem cells in alginate for muscle tissue engineering.

Jun Liu, Hongzhi Zhou, Michael D Weir, Hockin H K Xu, Qianming Chen, Carroll Ann Trotman

Registry-linked trialAbstract read
In one paragraph

Article in Tissue engineering. Part A, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00070811 (Functional Outcomes of Cleft Lip and Lip Revision Surgery), which is not on this map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00070811 completednot on this map

Functional Outcomes of Cleft Lip and Lip Revision Surgery

TypeobservationalSponsorUniversity of North Carolina, Chapel HillRan2001 to 2012Enrolled127ConditionsCleft Lip, Cleft Lip and PalateArmsLip revision surgery
3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jun LiuBiomaterials and Tissue Engineering Division, Department of Endodontics, Prosthodontics and Operative Dentistry, University of Maryland Dental School, Baltimore, Maryland 21201, USA.
Hongzhi Zhou
Michael D Weir
Hockin H K Xu
Qianming Chen
Carroll Ann Trotman

Funding

Functional Outcomes of Cleft Lip SurgeryR01DE013814 · NIDCR · UNIV OF NORTH CAROLINA CHAPEL HILL · PI TROTMAN, CARROLL ANN · 2001 to 2010
$5.0M
Injectable and Strong Nano-Apatite/Stem Cell Scaffolds for Bone RegenerationR01DE014190 · NIDCR · UNIVERSITY OF MARYLAND BALTIMORE · PI XU, HUAKUN · 2003 to 2013
$3.4M
Human Embryonic Stem Cells in Calcium Phosphate Constructs for Bone RegenerationR21DE022625 · NIDCR · UNIVERSITY OF MARYLAND BALTIMORE · PI XU, HUAKUN · 2012 to 2013
$413k
NIDCR NIH HHS R01 DE013814NIDCR NIH HHS R01 DE014190NIDCR NIH HHS R01 DE14190NIDCR NIH HHS R21 DE022625NIDCR NIH HHS R41 DE01974
6 · The paper itself

Abstract

Human umbilical cord mesenchymal stem cells (hUCMSCs) are inexhaustible and can be obtained without an invasive surgery. To date, there has been no report on seeding hUCMSCs in three-dimensional scaffolds for muscle tissue engineering. The objectives of this study were to (1) investigate hUCMSC seeding in a scaffold for muscle engineering and (2) develop a novel construct consisting of hUCMSC-encapsulating and fast-degradable microbeads inside a hydrogel matrix. The rationale was that the hydrogel matrix would maintain the defect volume, while the microbeads would degrade to release the cells and concomitantly create macropores in the matrix. hUCMSCs were encapsulated in alginate-fibrin microbeads, which were packed in an Arg-Gly-Asp (RGD)-modified alginate matrix (AM). This construct is referred to as hUCMSC-microbead-AM. The control consisted of the usual cell encapsulation in AM without microbeads (referred to as hUCMSC-AM). In the hUCMSC-AM construct, the hUCMSCs showed as round dots with no spreading at 1-14 days. In contrast, cells in the hUCMSC-microbead-AM construct had a healthy spreading and elongated morphology. The microbeads successfully degraded and released the cells at 8 days. Myogenic expressions for hUCMSC-microbead-AM were more than threefold those of hUCMSC-AM (p<0.05). Immunofluorescence for myogenic markers was much stronger for hUCMSC-microbead-AM than hUCMSC-AM. Muscle creatine kinase of hUCMSC-microbead-AM at 14 days was twofold that of hUCMSC-AM (p<0.05). In conclusion, hUCMSC encapsulation in novel fast-degradable microbeads inside a hydrogel matrix was investigated for muscle engineering. Compared to the usual method of seeding cells in a hydrogel matrix, hUCMSC-microbead-AM construct had greatly improved cell viability and myogenic differentiation, and hence, is promising to enhance muscle regeneration.

Indexed as

MicrospheresAlginatesBiodegradation, EnvironmentalCells, ImmobilizedCell SurvivalGene Expression RegulationGlucuronic AcidHexuronic AcidsHumansHydrogel, Polyethylene Glycol DimethacrylateMesenchymal Stem CellsMicroscopy, Electron, ScanningMuscle DevelopmentMusclesOligopeptidesStaining and LabelingAlginatesarginyl-glycyl-aspartic acidGlucuronic AcidHexuronic AcidsHydrogel, Polyethylene Glycol DimethacrylateOligopeptides

Identifiers

PMID22697426
PMCPMC3482877

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.